Ofatumumab to be pulled from non-US marketsJanuary 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Predicting response to AZA in MDS, CMMLJanuary 21, 2018AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Bright light therapy improves sleep in cancer survivorsJanuary 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Risks of MGUS persist beyond 30 yearsJanuary 18, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
CAR T-cell therapy on fast track in US, EUJanuary 18, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Drug’s label updated to include risk of allergic reactionsJanuary 17, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
FDA expands approval for arsenic trioxideJanuary 16, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML